ID: MRFR/MED/0240-HCR | February 2021 | Region: Global | 117 pages
Study objectives global advanced cardiovascular life support market
Figure 1- Global advanced cardiovascular life support market share by algorithm, 2016 (%)
Source- Annual reports, Press release, White paper, Company Presentation
Advanced cardiovascular life support is also referred as advanced cardiac life support is a set of clinical interventions for the emergency treatment of stroke and other life-threatening medical emergencies. According to WHO, more than 35% of the total global population were suffering from major or minor cardiovascular complication in 2015 and is the number one cause of death globally. Advanced cardiovascular life support is provided by well qualified health care personnel. The market growth of advanced cardiovascular life support is driven by the increasing number of cardiovascular diseases, coronary diseases and increasing demand for the emergency services. Other factors that propel the growth of market are continuous up gradation and modification of products, rising diabetic and obese population and excessive use of tobacco and alcohol. However, limited number of trained personnel has restrained of the growth of market.
The global advanced cardiovascular life support market is expected to grow at a CAGR of 7.0% during forecasted period 2017-2023.
Global advanced cardiovascular life support market is segmented on the basis of techniques, into airway management, non-invasive airway, endotracheal intubation, electrical therapy and lethal arrhythmias. On the basis of algorithm they are segmented into cardiac arrest, acute coronary syndromes, bradycardia, tachycardia, suspected stroke algorithms, and other. By instruments they are segmented into devices, accessories and other and on the basis of end users, the market is segmented into medical training centres, cardiac catheterization labs, hospital and other.
The regional analysis comprises of America, Europe, Asia Pacific, and Middle East & Africa. Global advanced cardiovascular life support market is dominated by America due to the rising number of patient suffering from cardiovascular diseases, well developed healthcare infrastructure and increasing aging population. Europe accounts for the second largest market which is followed by Asia Pacific. Asia Pacific is an emerging market for advanced cardiovascular life support. Increasing prevalence of cardiovascular diseases, a growing focus on the prevention, treatment and diagnosis of cardiovascular disease, changing lifestyle has led to the growth of market in Asia Pacific region.
Key players for global advanced cardiovascular life support market
CPR Medical Devices, Inc. (Canada), Cardiac Science Corporation (US), General Electric Company (US), Koninklijke Philips N.V. (the Netherlands), Michigan Instruments (US), Physio-Control, Inc. (US), Abbott (US), Asahi Kasei Corporation (Japan)
Source- World Health Organization (WHO), White paper, Company Presentation, American Heart Association, National Institutes of Health, Annual reports
The report for global advanced cardiovascular life support market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain the deeper insight of the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different markets segments and regions.